AVEO - AVEO Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue7,5792,51519,02418,123
Cost of Revenue25,17923,70312,87538,254
Gross Profit-17,600-21,1886,149-20,131
Operating Expenses
Research Development----
Selling General and Administrative9,1388,20510,21718,589
Non Recurring----
Others----
Total Operating Expenses34,31731,90823,09256,843
Operating Income or Loss-26,738-29,393-4,068-38,720
Income from Continuing Operations
Total Other Income/Expenses Net-38,1862,607-10,933-14,019
Earnings Before Interest and Taxes-26,738-29,393-4,068-38,720
Interest Expense-2,373-1,949-2,286-2,356
Income Before Tax-64,924-26,786-15,001-52,739
Income Tax Expense101101--
Minority Interest----
Net Income From Continuing Ops-65,025-26,887-15,001-52,739
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-65,025-26,887-15,001-52,739
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-65,025-26,887-15,001-52,739